In this study we compared anti-tumor effects of type I and type III IFNs with 5 kinds of p53-wild type mesothelioma cells, and investigated a possible up-regulation of p53 and combinatory effects of IFN with the first-line chemotherapeutic agents. Here, TP53 is linked to neoplasm.